SENORES PHARMACEUTICALS L Asset Resilience Ratio

Latest as of March 2026: 17.88%

SENORES PHARMACEUTICALS L asset resilience ratio. SENORES PHARMACEUTICALS L (SENORES) has an Asset Resilience Ratio of 17.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can SENORES PHARMACEUTICALS L fund operations to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs2.87 Billion

≈ $31.01 Million USD Cash + Short-term Investments

Total Assets

Rs16.04 Billion

≈ $173.45 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of SENORES PHARMACEUTICALS L (2022–2026)

Asset resilience ratio of SENORES PHARMACEUTICALS L from 2022 to 2026. This chart shows how SENORES PHARMACEUTICALS L's Asset Resilience Ratio has changed over time. Read SENORES total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down SENORES PHARMACEUTICALS L's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SENORES current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs2.87 Billion	17.88%
Total Liquid Assets	Rs2.87 Billion	17.88%

Asset Resilience Insights

Good Liquidity Position: SENORES PHARMACEUTICALS L maintains a healthy 17.88% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

SENORES PHARMACEUTICALS L Industry Peers by Asset Resilience Ratio

Compare SENORES PHARMACEUTICALS L's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Novartis AG SW:NOVN	Drug Manufacturers - General	0.08%
Virbac SA PA:VIRP	Drug Manufacturers - General	0.23%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.06%
Zhejiang Int'L Group Co Ltd SHE:000411	Drug Manufacturers - General	0.00%
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	Drug Manufacturers - General	1.97%
Hubei Guangji Pharmaceutical Co Ltd SHE:000952	Drug Manufacturers - General	5.37%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%

SENORES PHARMACEUTICALS L Asset Resilience Ratio by Year (2022–2026)

SENORES PHARMACEUTICALS L asset resilience ratio by year from 2022 to 2026. The table below shows the annual Asset Resilience Ratio data for SENORES PHARMACEUTICALS L.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	17.88%	Rs2.87 Billion ≈ $31.01 Million	Rs16.04 Billion ≈ $173.45 Million	+17.04pp
2024-03-31	0.84%	Rs52.08 Million ≈ $563.23K	Rs6.22 Billion ≈ $67.25 Million	-1.18pp
2022-03-31	2.02%	Rs11.95 Million ≈ $129.23K	Rs591.52 Million ≈ $6.40 Million	--

pp = percentage points

About SENORES PHARMACEUTICALS L

NSE:SENORES India Drug Manufacturers - General

Market Cap

$557.62 Million

Rs51.56 Billion INR

Market Cap Rank

#11348 Global

#566 in India

Share Price

Rs1119.60

Change (1 day)

-1.26%

52-Week Range

Rs710.25 - Rs1550.90

All Time High

Rs1550.90